INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,479,008 | -44.7% | 335,554 | -32.8% | 1.30% | -39.7% |
Q2 2023 | $31,628,530 | +44.5% | 499,503 | +20.8% | 2.16% | +12.8% |
Q4 2022 | $21,882,790 | +20.4% | 413,507 | +5.8% | 1.92% | +13.8% |
Q3 2022 | $18,178,000 | -26.6% | 390,678 | -10.0% | 1.68% | -28.0% |
Q2 2022 | $24,770,000 | -28.0% | 433,959 | -22.8% | 2.34% | -4.4% |
Q1 2022 | $34,412,000 | +0.7% | 562,373 | -13.9% | 2.45% | +13.2% |
Q4 2021 | $34,172,000 | +49.5% | 652,886 | +6.5% | 2.16% | +29.6% |
Q3 2021 | $22,861,000 | -6.4% | 613,212 | +2.5% | 1.67% | +8.9% |
Q2 2021 | $24,421,000 | +29.8% | 598,261 | +7.9% | 1.53% | +16.8% |
Q1 2021 | $18,816,000 | +51.6% | 554,545 | +42.1% | 1.31% | +36.8% |
Q4 2020 | $12,411,000 | +5.7% | 390,289 | -14.7% | 0.96% | -24.5% |
Q3 2020 | $11,745,000 | +1685.0% | 457,720 | +960.0% | 1.27% | +2786.4% |
Q3 2016 | $658,000 | -63.5% | 43,181 | -6.9% | 0.04% | -64.8% |
Q2 2016 | $1,801,000 | +592.7% | 46,400 | +470.7% | 0.12% | +635.3% |
Q2 2015 | $260,000 | – | 8,130 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |